These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 4285449

  • 1. The treatment of multiple sclerosis with ACTH.
    Stetzler W.
    Minn Med; 1966 Feb; 49(2):323-9. PubMed ID: 4285449
    [No Abstract] [Full Text] [Related]

  • 2. Home intravenous administration of adrenocorticotropic hormone in patients with multiple sclerosis.
    Molitor RE, Stewart J.
    J Intraven Nurs; 1988 Feb; 11(4):249-51. PubMed ID: 2843618
    [No Abstract] [Full Text] [Related]

  • 3. A critical evaluation and review of ACTH (corticotrophin) in the treatment of acute exacerbations of multiple sclerosis.
    Blustein H, Wasserman RR, Halperin L, Garvin JS.
    Med Times; 1969 Dec; 97(12):137-41. PubMed ID: 4312534
    [No Abstract] [Full Text] [Related]

  • 4. [Pathogenesis and treatment of multiple sclerosis. Review and personal results].
    Gérard JM, Hildebrand J, Mavroudakis N, Monseu G, Przedborski S, Seeldrayers P, Wautier J, Zegers de Beyl D.
    Rev Med Brux; 1988 Sep; 9(6):334-9. PubMed ID: 2845554
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of high doses of synthetic ACTH on the function of the hypothalamo-hypophyseal-adrenal cortex system].
    Walser A, Barthe P, Schär J.
    Schweiz Med Wochenschr; 1968 Nov 30; 98(48):1892-5. PubMed ID: 4303138
    [No Abstract] [Full Text] [Related]

  • 6. [ACTH in the treatment of multiple sclerosis].
    Palazzoli A, De Lorenzi L, Paiardi A.
    Boll Soc Med Chir Cremona; 1967 Nov 30; 21(3):147-60. PubMed ID: 4299611
    [No Abstract] [Full Text] [Related]

  • 7. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH.
    Maciejek Z, Rebeś Z, Kubasiewicz B.
    Arch Immunol Ther Exp (Warsz); 1981 Nov 30; 29(2):141-4. PubMed ID: 6272663
    [Abstract] [Full Text] [Related]

  • 8. Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.
    Kopff M, Zakrzewska I, Klem J, Puczkowski S, Strzelczyk M, Czernicki J, Chmielewski H.
    Pol J Pharmacol; 1995 Nov 30; 47(6):525-30. PubMed ID: 8868375
    [Abstract] [Full Text] [Related]

  • 9. [ACTH treatment of multiple sclerosis].
    Boman K, Hokkanen E, Jarho L, Kivalo E.
    Duodecim; 1966 Nov 30; 82(18):867-73. PubMed ID: 4288673
    [No Abstract] [Full Text] [Related]

  • 10. [Experiences with ACTH treatment of multiple sclerosis].
    Schär J.
    Schweiz Med Wochenschr; 1965 Sep 25; 95(39):1289-96. PubMed ID: 4285803
    [No Abstract] [Full Text] [Related]

  • 11. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC.
    NITA; 1985 Sep 25; 8(6):503-5. PubMed ID: 2999647
    [No Abstract] [Full Text] [Related]

  • 12. The management of multiple sclerosis. II. Serial neurologic examinations and use of corticotropin and glucocorticoids.
    McFarland HR.
    Mo Med; 1969 Feb 25; 66(2):113-6. PubMed ID: 4302927
    [No Abstract] [Full Text] [Related]

  • 13. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
    Sigwald J, Mazalton A, Raymondeaud C, Piot C, Jacquillat C.
    Rev Neurol (Paris); 1973 Jan 25; 128(1):72-7. PubMed ID: 4367744
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of ACTH and corticosteroid therapy in multiple sclerosis].
    Hamel-Puskarić N, Arko K, Dupelj M, Novak Z, Barac B, Czukor M.
    Neuropsihijatrija; 1969 Jan 25; 17(1):51-70. PubMed ID: 4191305
    [No Abstract] [Full Text] [Related]

  • 15. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbation.
    Rose AS, Kuzma JW, Kurtzke JF, Sibley WA, Tourtellotte WW.
    Trans Am Neurol Assoc; 1969 Jan 25; 94():126-33. PubMed ID: 4313957
    [No Abstract] [Full Text] [Related]

  • 16. [Experience with the therapy of multiple sclerosis using ACTH].
    Carella A, Lamberti P.
    Acta Neurol (Napoli); 1969 Jan 25; 24(6):836-51. PubMed ID: 4314191
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of multiple sclerosis with Lyoproper].
    Aschoff JC, Conrad B.
    Med Klin; 1971 Jun 23; 66(30):1055-8. PubMed ID: 4328079
    [No Abstract] [Full Text] [Related]

  • 18. [Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
    Wender M, Tokarz-Kupczyk E, Mularek O.
    Neurol Neurochir Pol; 1988 Jun 23; 22(5):399-403. PubMed ID: 2854886
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of multiple sclerosis].
    Arasa F.
    Folia Clin Int (Barc); 1969 Jan 23; 19(1):7-23. PubMed ID: 4308450
    [No Abstract] [Full Text] [Related]

  • 20. Autologous lymphocyte proliferation in multiple sclerosis and the effect of intravenous ACTH.
    Birnbaum G, Kotilinek L.
    Ann Neurol; 1981 May 23; 9(5):439-46. PubMed ID: 6267984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.